Modifying Risk Factors: Strategies That Work Diabetes Mellitus

Journal of Arthroplasty

Volumn 31, Issue 8, 2016, Pages 1625-1627

  Stryker, Louis S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

diabetes; hyperglycemia; preoperative optimization; risk factors; total joint athroplasty

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL;

ARTHROPLASTY; ARTICLE; CLINICAL PROTOCOL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH CARE COST; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; PATIENT CARE; PEROPERATIVE COMPLICATION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; REFERENCE VALUE; RISK REDUCTION; TREATMENT OUTCOME; WOUND COMPLICATION; ANALYSIS; BLOOD; COMPLICATION; DIABETES COMPLICATIONS; JOINT DISEASES; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; REPLACEMENT ARTHROPLASTY; RETROSPECTIVE STUDY; RISK FACTOR;

ARTHROPLASTY, REPLACEMENT; BLOOD GLUCOSE; DIABETES COMPLICATIONS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; JOINT DISEASES; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84964289621     PISSN: 08835403     EISSN: 15328406     Source Type: Journal    
DOI: 10.1016/j.arth.2016.02.084     Document Type: Article

References (36)

1. 1 Centers for Disease Control and Prevention. Diabetes Report Card 2014. 2015, Centers for Disease Control and Prevention, US Dept of Health and Human Services, Atlanta, GA.
2. 2 Narayan, K.M.V., Boyle, J.P., Geiss, L.S., et al. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care, 29, 2006, 2114.
3. 3 Nathan, D.M., Long-term complications of diabetes mellitus. N Engl J Med, 328, 1993, 1676.
4. 4 Montori, V.M., Bistrian, B.R., McMahon, M.M., Hyperglycemia in acutely ill patients. JAMA, 288, 2002, 2167.
5. 5 Halkos, M.E., Puskas, J.D., Lattouf, O.M., et al. Elevated preoperative hemoglobin A1c level is predictive of adverse events after coronary artery bypass surgery. J Thorac Cardiovasc Surg, 136, 2008, 631.
6. 6 Furnary, A.P., Clinical benefits of tight glycaemic control: focus on the perioperative setting. Best Pract Res Clin Anaesthesiol, 23, 2009, 411.
7. 7 Ling, P.-R., Smith, R.J., Bistrian, B.R., Acute effects of hyperglycemia and hyperinsulinemia on hepatic oxidative stress and the systemic inflammatory response in rats. Crit Care Med, 35, 2007, 555.
8. 8 King, K.B., Findley, T.W., Williams, A.E., et al. Veterans with diabetes receive arthroplasty more frequently and at a younger age. Clin Orthop Relat Res, 471, 2013, 3049.
9. 9 Serna, F., Mont, M.A., Krackow, K.A., et al. Total knee arthroplasty in diabetic patients. Comparison to a matched control group. J Arthroplasty, 9, 1994, 375.
10. 10 Menon, T.J., Thjellesen, D., Wroblewski, B.M., Charnley low-friction arthroplasty in diabetic patients. J Bone Joint Surg Br, 65, 1983, 580.
11. 11 Marchant, M.H. Jr., The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am, 91, 2009, 1621.
12. 12 Mednick, R.E., Alvi, H.M., Krishnan, V., et al. Factors affecting readmission rates following primary total hip arthroplasty. J Bone Joint Surg Am, 96, 2014, 1201.
13. 13 Chrastil, J., Anderson, M.B., Stevens, V., et al. Is hemoglobin A1c or perioperative hyperglycemia predictive of periprosthetic joint infection or death following primary total joint arthroplasty?. J Arthroplasty, 30, 2015, 1197.
14. 14 Wang, S., Zhao, Y., Diabetes mellitus and the incidence of deep vein thrombosis after total knee arthroplasty: a retrospective study. J Arthroplasty, 28, 2013, 595.
15. 15 Iorio, R., Williams, K.M., Marcantonio, A.J., et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J Arthroplasty, 27, 2012, 726.
16. 16 Bolognesi, M.P., Marchant, M.H. Jr., Viens, N.A., et al. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplasty, 23, 2008, 92.
17. 17 Jämsen, E., Nevalainen, P., Eskelinen, A., et al. Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection. J Bone Joint Surg Am, 94, 2012, e1011.
18. 18 Belmont, P.J. Jr., Goodman, G.P., Waterman, B.R., et al. Thirty-day postoperative complications and mortality following total knee arthroplasty. J Bone Joint Surg Am, 96, 2014, 20.
19. 19 O'Toole, P., Maltenfort, M.G., Chen, A.F., et al. Projected increase in periprosthetic joint infections secondary to rise in diabetes and obesity. J Arthroplasty, 31, 2016, 7.
20. 20 Mraovic, B., Hipszer, B.R., Epstein, R.H., et al. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty, 25, 2010, 64.
21. 21 Underwood, P., Askari, R., Hurwitz, S., et al. Preoperative A1C and clinical outcomes in patients with diabetes undergoing major noncardiac surgical procedures. Diabetes Care, 37, 2014, 611.
22. 22 Jämsen, E., Nevalainen, P., Kalliovalkama, J., et al. Preoperative hyperglycemia predicts infected total knee replacement. Eur J Intern Med, 21, 2010, 196.
23. 23 Maradit Kremers, H., Lewallen, L.W., Mabry, T.M., et al. Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty. J Arthroplasty, 30, 2015, 439.
24. 24 Standards of medical care in diabetes-2016: summary of revisions. Diabetes Care, 39(Suppl 1), 2016, S4.
25. 25 Harris, A.H.S., Bowe, T.R., Gupta, S., et al. Hemoglobin A1C as a marker for surgical risk in diabetic patients undergoing total joint arthroplasty. J Arthroplasty, 28, 2013, 25.
26. 26 Stryker, L.S., Abdel, M.P., Morrey, M.E., et al. Elevated postoperative blood glucose and preoperative hemoglobin A1C are associated with increased wound complications following total joint arthroplasty. J Bone Joint Surg Am, 95, 2013, 808 S1.
27. 27 Dronge, A.S., Perkal, M.F., Kancir, S., et al. Long-term glycemic control and postoperative infectious complications. Arch Surg, 141, 2006, 375 discussion 380.
28. 28 Giori, N.J., Ellerbe, L.S., Bowe, T., et al. Many diabetic total joint arthroplasty candidates are unable to achieve a preoperative hemoglobin A1c goal of 7% or less. J Bone Joint Surg Am, 96, 2014, 500.
29. 29 Adams, A.L., Surgical outcomes of total knee replacement according to diabetes status and glycemic control, 2001 to 2009. J Bone Joint Surg Am, 95(6), 2013, 481.
30. 30 Boulé, N.G., Haddad, E., Kenny, G.P., et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials. Jama, 286, 2001, 1218.
31. 31 Capes, S.E., Hunt, D., Malmberg, K., et al. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke, 32, 2001, 2426.
32. 32 Mraovic, B., Suh, D., Jacovides, C., et al. Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty. J Diabetes Sci Technol, 5, 2011, 412.
33. 33 Richards, J.E., Kauffmann, R.M., Zuckerman, S.L., et al. Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery. J Bone Joint Surg Am, 94, 2012, 1.
34. 34 Wiener, R.S., Wiener, D.C., Larson, R.J., Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA, 300, 2008, 933.
35. 35 Buchleitner, A.M., Martínez-Alonso, M., Hernández, M., et al. Perioperative glycaemic control for diabetic patients undergoing surgery. 2012, John Wiley & Sons, Ltd, Chichester, UK.
36. 36 Duncan, A.E., Hyperglycemia and perioperative glucose management. Curr Pharm Des, 18, 2012, 6195.